CCR5 and neoplasm: Accordingly, the therapeutic use of the CCR5 inhibitor maraviroc in patients with advanced-stage metastatic colorectal cancer resulted in the marked induction of tumor cell death and decreased tumor cell proliferation within metastatic lesions, while the number of infiltrating CD8+ T cells detected in the invasive margin of liver metastasis remained mostly stable [57].